Nanobiotix SA
PAR:NANO

Watchlist Manager

Nanobiotix SA

PAR:NANO

Watchlist

Dividends

Price: 2.948 EUR 0.41% Market Closed

Market Cap: 138.9m EUR

Have any thoughts about
Nanobiotix SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 2.948 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NANO Alert

Nanobiotix SA

2.948

+0.012 (+0.41%)

52 Week Range	2.706 6.79
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Nanobiotix SA

What unique competitive advantages
does Nanobiotix SA hold over its rivals?

What risks and challenges
does Nanobiotix SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Nanobiotix SA.

What unique competitive advantages
does Nanobiotix SA hold over its rivals?

What risks and challenges
does Nanobiotix SA face in the near future?

Has there been any significant insider trading activity
in Nanobiotix SA recently?

Summarize the latest earnings call
of Nanobiotix SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nanobiotix SA.

Provide P/S
for Nanobiotix SA.

Provide P/E
for Nanobiotix SA.

Provide P/OCF
for Nanobiotix SA.

Provide P/FCFE
for Nanobiotix SA.

Provide P/B
for Nanobiotix SA.

Provide EV/S
for Nanobiotix SA.

Provide EV/GP
for Nanobiotix SA.

Provide EV/EBITDA
for Nanobiotix SA.

Provide EV/EBIT
for Nanobiotix SA.

Provide EV/OCF
for Nanobiotix SA.

Provide EV/FCFF
for Nanobiotix SA.

Provide EV/IC
for Nanobiotix SA.

Show me price targets
for Nanobiotix SA made by professional analysts.

What are the Revenue projections
for Nanobiotix SA?

How accurate were the past Revenue estimates
for Nanobiotix SA?

What are the Net Income projections
for Nanobiotix SA?

How accurate were the past Net Income estimates
for Nanobiotix SA?

What are the EPS projections
for Nanobiotix SA?

How accurate were the past EPS estimates
for Nanobiotix SA?

What are the EBIT projections
for Nanobiotix SA?

How accurate were the past EBIT estimates
for Nanobiotix SA?

Compare the revenue forecasts
for Nanobiotix SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nanobiotix SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nanobiotix SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nanobiotix SA compared to its peers.

Compare the P/E ratios
of Nanobiotix SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Nanobiotix SA with its peers.

Analyze the financial leverage
of Nanobiotix SA compared to its main competitors.

Show all profitability ratios
for Nanobiotix SA.

Provide ROE
for Nanobiotix SA.

Provide ROA
for Nanobiotix SA.

Provide ROIC
for Nanobiotix SA.

Provide ROCE
for Nanobiotix SA.

Provide Gross Margin
for Nanobiotix SA.

Provide Operating Margin
for Nanobiotix SA.

Provide Net Margin
for Nanobiotix SA.

Provide FCF Margin
for Nanobiotix SA.

Show all solvency ratios
for Nanobiotix SA.

Provide D/E Ratio
for Nanobiotix SA.

Provide D/A Ratio
for Nanobiotix SA.

Provide Interest Coverage Ratio
for Nanobiotix SA.

Provide Altman Z-Score Ratio
for Nanobiotix SA.

Provide Quick Ratio
for Nanobiotix SA.

Provide Current Ratio
for Nanobiotix SA.

Provide Cash Ratio
for Nanobiotix SA.

What is the historical Revenue growth
over the last 5 years for Nanobiotix SA?

What is the historical Net Income growth
over the last 5 years for Nanobiotix SA?

What is the current Free Cash Flow
of Nanobiotix SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nanobiotix SA.

Nanobiotix SA
Investor Relations

Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 100 full-time employees. The company went IPO on 2012-10-29. The firm is engaged in developing nanoparticle technology. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The firm develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) plays a seminal role in the potential cure and gives the systemic treatment a better chance to increase life expectancy. NanoXray products are developed to selectively increase the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

NANO

DAX Index

1Y 3Y 5Y 10Y 15Y 20Y

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nanobiotix SA

Business Overview

Earnings Calls

Show Transcript

Management

Mr. Laurent Levy Ph.D.

Co-Founder, President of the Executive Board & CEO

No Bio Available

Mr. Bart Van Rhijn

Chief Financial & Business Officer and Member of Executive Board

No Bio Available

Ms. Anne-Juliette Hermant M.A.

Chief People Officer & Member of Executive Board

No Bio Available

Dr. Louis Kayitalire M.D.

Chief Medical Officer

No Bio Available

Mr. Earl J. Bergey Ph.d.

Co-Founder

No Bio Available

Mr. Craig West CFA

Senior Vice President of Investor Relations

No Bio Available

Mr. Brandon Owens

VP of Strategic Marketing & Corporate Communication

No Bio Available

Ms. Margaret Galluzzi

VP & Global Head of Clinical Operations

No Bio Available

Dr. Leonard A. Farber M.D.

Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board

No Bio Available

Contacts

Address

ILE-DE-FRANCE

Paris

60 rue de Wattignies

Contacts

+33140260470.0

www.nanobiotix.com

sparklesyt

	Franklin Covey Co NYSE:FC	30.6 USD 2.55%
	Mohawk Industries Inc NYSE:MHK	114.3 USD 3.05%
	Ardmore Shipping Corp NYSE:ASC	9.89 USD 0.41%
	ASGN Inc NYSE:ASGN	68.05 USD 1.52%
	Skyworks Solutions Inc NASDAQ:SWKS	69.4 USD 3.29%
	Weatherford International PLC NASDAQ:WFRD	53.11 USD 2.35%

	Johnson & Johnson NYSE:JNJ	162.81 USD -0.11%
	Bank of America Corp NYSE:BAC	40.89 USD 3.08%
	Mastercard Inc NYSE:MA	527.64 USD 1.5%
	Salesforce Inc NYSE:CRM	279.4 USD 2.82%
	Abbvie Inc NYSE:ABBV	211.77 USD 0.1%
	Home Depot Inc NYSE:HD	351.31 USD 1.17%

	Arista Networks Inc NYSE:ANET	83.51 USD 4.21%
	Visa Inc NYSE:V	331.8 USD 0.99%
	Texas Pacific Land Corp NYSE:TPL	1 321.07 USD 5.28%
	KLA Corp NASDAQ:KLAC	713 USD 4.62%
	Manhattan Associates Inc NASDAQ:MANH	172.5 USD 5.5%
	Monolithic Power Systems Inc NASDAQ:MPWR	606.06 USD 6.1%

	ServiceNow Inc NYSE:NOW	844.33 USD 4.03%
	EOG Resources Inc NYSE:EOG	123.92 USD 2.34%
	Monster Beverage Corp NASDAQ:MNST	55.09 USD 1.38%
	Copart Inc NASDAQ:CPRT	52.65 USD 0.67%
	Applied Materials Inc NASDAQ:AMAT	155.66 USD 3.81%
	Airbnb Inc NASDAQ:ABNB	122.86 USD 2.92%

Nanobiotix SA
PAR:NANO

Nanobiotix SA
Investor Relations

Earnings Calls

Management

Contacts

See Also

Company

Help

Tools

Stocks

Nanobiotix SA PAR:NANO

Nanobiotix SA Investor Relations

Earnings Calls

Management

Contacts

See Also

Company

Help

Tools

Stocks

Nanobiotix SA
PAR:NANO

Nanobiotix SA
Investor Relations